Vered M, Wright JM (2022) Update from the 5th Edition of the World Health Organization Classification of Head and Neck tumors: odontogenic and maxillofacial bone tumours. Head Neck Pathol 16:63–75. https://doi.org/10.1007/s12105-021-01404-7

Article  PubMed  PubMed Central  Google Scholar 

Gültekin SE, Aziz R, Heydt C, Sengüven B, Zöller J, Safi AF, Kreppel M, Buettner R (2018) The landscape of genetic alterations in ameloblastomas relates to clinical features. Virchows Arch 472(5):807–814. https://doi.org/10.1007/s00428-018-2305-5

Article  PubMed  PubMed Central  Google Scholar 

Hendra FN, Van Cann EM, Helder MN, Ruslin M, de Visscher JG, Forouzanfar T, Vet HCW (2020) Global incidence and profile of ameloblastoma: a systematic review and meta-analysis. Oral Dis 26(1):12–21. https://doi.org/10.1111/odi.13031

Article  PubMed  Google Scholar 

Kreppel M, Zöller J (2018) Ameloblastoma-Clinical, radiological, and therapeutic findings. Oral Dis 24(1–2):63–66. https://doi.org/10.1111/odi.12702

Article  CAS  PubMed  Google Scholar 

Effiom O, Ogundana O, Akinshipo A, Akintoye S (2017) Ameloblastoma: current etiopathological concepts and management. Oral Dis 24(3):307–316. https://doi.org/10.1111/odi.12646

Article  PubMed  Google Scholar 

Hendra FN, Natsir Kalla DS, Van Cann EM, de Vet HCW, Helder MN, Forouzanfar T (2019) Radical vs conservative treatment of intraosseous ameloblastoma: systematic review and meta-analysis. Oral Dis 25(7):1683–1696. https://doi.org/10.1111/odi.13014

Article  PubMed  Google Scholar 

Bi L, Wei D, Hong D, Wang J, Qian K, Wang H, Zhu H (2021) A retrospective study of 158 cases on the risk factors for recurrence in ameloblastoma. Int J Med Sci 18(14):3326–3332. https://doi.org/10.7150/ijms.61500

Article  PubMed  PubMed Central  Google Scholar 

‌ ‌Au SW, Li KY, Choi WS, Su YX (2019) Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study. Int J Oral Maxillofac Surg 48(10):1300–1306. https://doi.org/10.1016/j.ijom.2019.04.008

Article  PubMed  Google Scholar 

Bologna-Molina R, Pereira-Prado V, Sanchez-Romero C, Tapia-Repetto G, Soria S, Hernandez M, Gonzalez-Gonzalez R, Molina-Frechero M, Mikami T (2018) Expression of hMLH1 and hMSH2 proteins in ameloblastomas and tooth germs. Med Oral Patol Oral Cir Bucal 23(2):e126–e131. https://doi.org/10.4317/medoral.22210

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pećina-Šlaus N, Kafka A, Salamon I, Bukovac A (2020) Mismatch repair pathway, genome stability and cancer. Front Mol Biosci 26:7:122. https://doi.org/10.3389/fmolb.2020.00122

Article  CAS  Google Scholar 

Monteiro BBV, Cavalcante RB, Nogueira RLM, Miguel MMC, Nonaka CFW, Silveira ÉJD (2015) Participation of hMLH1, p63, and MDM2 proteins in the pathogenesis of syndromic and nonsyndromic keratocystic odontogenic tumors. Oral surgery, oral medicine. Oral Pathol Oral Radiol 120(1):52–57. https://doi.org/10.1016/j.oooo.2015.03.011

Article  Google Scholar 

Yang R, Liu Z, Peng C, Cao W, Ji T (2017) Maxillary ameloblastoma: factors associated with risk of recurrence. Head Neck 39(5):996–1000. https://doi.org/10.1002/hed.24720

Article  PubMed  Google Scholar 

Amaral-Silva GK, Sánchez-Romero C, Wagner VP, Martins MD, Pontes HAR, Fregnani ER, Soares FA, Almeida OP, Rocha AC, Santos-Silva AR, Fonseca FP, Vargas PA (2017) Prognostic significance of hMSH2, hMSH3, and hMSH6 expression in ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 124(3):286–295. https://doi.org/10.1016/j.oooo.2017.05.511

Article  Google Scholar 

Fernandes GS, Girardi DM, Bernardes JPG, Fonseca FP, Fregnani ER (2018) Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation. BMC Cancer 18(1):887. https://doi.org/10.1186/s12885-018-4802-y

Article  PubMed  PubMed Central  Google Scholar 

Singh T, Wiesenfeld D, Clement J, Chandu A, Nastri A (2015) Ameloblastoma: demographic data and treatment outcomes from Melbourne, Australia. Aust Dent J 60(1):24–29. https://doi.org/10.1111/adj.12244

Article  CAS  PubMed  Google Scholar 

Laborde A, Nicot R, Wojcik T, Ferri J, Raoul G (2017) Ameloblastoma of the jaws: management and recurrence rate. Eur Ann Otorhinolaryngol Head Neck Dis 134(1):7–11. https://doi.org/10.1016/j.anorl.2016.09.004

Article  CAS  PubMed  Google Scholar 

Jaeger F, Saturnino M, Silva FB, Soraya M, Alencar E, Cássia M, Mesquita RA (2017) Prevalence profile of odontogenic cysts and tumors on Brazilian sample after the reclassification of odontogenic keratocyst. J Craniomaxillofac Surg 45(2):267–270. https://doi.org/10.1016/j.jcms.2016.12.011

Article  PubMed  Google Scholar 

de Medeiros W, da Silva L, Santos P, Pinto L, de Souza L (2018) Clinicopathological analysis of odontogenic tumors diseas 22 years period: Experience of a single center in northeastern Brazil. Med Oral Patol Oral Cir Bucal, 1;23(6):e664-e671. https://doi.org/10.4317/medoral.22618

Aregbesola B, Soyele O, Effiom O, Gbotolorun O, Taiwo O, Amole I (2018) Odontogenic tumours in Nigeria: a multicentre study of 582 cases and review of the literature. Med Oral Patol Oral Cir Bucal 23(6):e761–e766. https://doi.org/10.4317/medoral.22473

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dandriyal R, Lal V, Giri KY, Bavanthabettu NI, Chaurasia A, Pant S (2022) Ameloblastoma: Retrospective Study and Analysis of 102 cases over 10 years, single centre, institutional experience. J Oral Maxillofac Surg 21(2):730–738. https://doi.org/10.1007/s12663-022-01694-6

Article  Google Scholar 

McClary AC, West RB, McClary AC, Pollack JR, Fischbein NJ, Holsinger CF, Sunwoo J, Colevas AD, Sirjani D (2015) Ameloblastoma: a clinical review and trends in management. Eur Arch Otorhinolaryngol 273(7):1649–1661. https://doi.org/10.1007/s00405-015-3631-8

Article  PubMed  Google Scholar 

Milman T, Ying G-S, Pan W, LiVolsi V (2016) Ameloblastoma: 25-year experience at a single institution. Head Neck Pathol 10(4):513–520. https://doi.org/10.1007/s12105-016-0734-5

Article  PubMed  PubMed Central  Google Scholar 

Al-Moraissi EA, Dahan AA, Alwadeai MS, Oginni FO, Al-Jamali J, Alkhutari AS, Al-Tairi NH, Almaweri AA, Al-Sanabani JS (2017) What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor? A large systematic review and meta-analysis. J Craniomaxillofac Surg 45(1):131–144. https://doi.org/10.1016/j.jcms.2016.10.013

Article  PubMed  Google Scholar 

Castrilli G, Piantelli M, Artese L, Perfetti G, Rubini C, Fioroni M, Ranelletti FO, Piattelli A (2001) Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in ameloblastoma. J Oral Pathol Med 30(5):305–308. https://doi.org/10.1034/j.1600-0714.2001.300508.x

Article  CAS  PubMed  Google Scholar 

Piantelli GCM, Artese L, Perfetti G, Rubini C, Fioroni MRFO, Piattelli A (2001) Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in ameloblastoma. J Oral Pathol Med 30(5):305–308. https://doi.org/10.1034/j.1600-0714.2001.300508.x

Article  PubMed  Google Scholar 

Kato M, Takano M, Miyamoto M, Sasaki N, Goto T, Tsuda H, Furuya K (2015) DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers. J Gynecol Oncol 26(1):40–45. https://doi.org/10.3802/jgo.2015.26.1.40

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wagner VP, Webber LP, Salvadori G, Meurer L, Fonseca FP, Castilho RM, Squarize CH, Vargas PA, Martins MD (2016) Overexpression of MutSα Complex proteins predicts poor prognosis in oral squamous cell carcinoma. Medicine 95(22):e3725. https://doi.org/10.1097/MD.0000000000003725

Article  CAS  PubMed  PubMed Central  Google Scholar 

Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, Point D, Tsourouflis G, Sastre-Garau X (2011) Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients’. Survival J Oral Pathol Med 40(3):218–226. https://doi.org/10.1111/j.1600-0714.2010.00945.x

Article  CAS  PubMed  Google Scholar 

Ahlem B, Wided A, Amani L, Nadia Z, Amira A, Faten F (2015) Study of Ki67 and CD10 expression as predictive factors of recurrence of ameloblastoma. Eur Ann Otorhinolaryngol Head Neck Dis 132(5):275–2799. https://doi.org/10.1016/j.anorl.2015.08.016

Article  CAS